Participating in open and frank conversations can be a catalyst for both positive change and a better industry. As we share our perspective you will find:
- Relevant and timely industry information
- Medication trends, and their impact
- Case studies, and the results of their related projects
- Special-subject on-demand webinars
Articles and blogs
Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.
|
October 26, 2020 · Clinical Team
Veklury® (remdesivir) is the first medication to be approved for the treatment of coronavirus disease 2019 (COVID-19) by the U.S. Food and Drug Administration (FDA) on October 22, 2020. Read more... |
|
October 20, 2020 · Optum Workers' Comp and Auto No-fault
The National Alliance of Medicare Set-Aside Professionals (NAMSAP), now known as the National Medicare Secondary Payer Network, continues to hit it out of the park at their annual conference. Read more... |
|
October 19, 2020 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
October 14, 2020 · Clinical Team
The U.S. Food and Drug Administration (FDA) reported that the brand-name opioid analgesic, Duragesic (fentanyl transdermal system), manufactured by Janssen Pharmaceuticals, Inc., is being discontinued. According to the FDA’s website, Janssen made a business decision to permanently discontinue all Duragesic transdermal systems and indicated they should be maintained on formularies until the last produced batch expires on July 31, 2021 to maintain continuity of the reimbursement process. No additional information was provided on Janssen’s website related to its business decision. Read more... |
|
October 11, 2020 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more... |
|
|
October 09, 2020 · Optum Workers' Comp and Auto No-fault
The Centers for Medicare and Medicaid Services (CMS) released Version 3.2 of the Workers’ Compensation Medicare Set-Aside Arrangement (WCMSA) Reference Guide, which clears up how pricing is determined for services rendered at a major medical center. Read more... |
Page 1 of 17
Subscribe today to receive our latest blogs, articles and more.
Additional Resources
Case Studies
Industry Trends Report
Continuing Education
